Pulmonary Mucormycosis Presenting as Nonresolving Pneumonia in a Patient With Diabetes Mellitus

Petrikkos G , Skiada A , Lortholary O , Roilides E , Walsh TJ , Kontoyiannis DP . Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis, 2012; 54(Suppl 1):S23–S34.

Chamilos G , Kontoyiannis DP . Aspergillus, Candida, and other opportunistic mold infections of the lung. In: Fishman AP , Elias JA , Fishman JA , Grippi MA , Senior RM , Pack AI , editors. Fishman's pulmonary diseases and disorders, 4th edition, volume 2. New York: McGraw-Hill; 2008; 2291–2326.

Karnak D , Avery RK , Gildea TR , Sahoo D , Mehta AC . Endobronchial fungal disease: an under-recognized entity. Respiration, 2007; 74(1):88–104.

Di Carlo P , Cabibi D , La Rocca AM , De Luca D , La Licata F , Sacco E . Post-bronchoscopy fatal endobronchial hemorrhage in a woman with bronchopulmonary mucormycosis: a case report. J Med Case Rep, 2010; 4:398.

Chamilos G , Marom EM , Lewis RE , Lionakis MS , Kontoyiannis DP . Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis, 2005; 41(1):60–66.

Weyers CM , Leeper KV . Nonresolving pneumonia. Clin Chest Med, 2005; 26(1):143–158.

Ljubic S , Balachandran A , Pavlic-Renar I , Barada A , Metelko Z . Pulmonary infections in diabetes mellitus. Diabetol Croat, 2004; 33(4):115–124.

Greenberg RN , Mullane K , van Burik JA , Raad I , Abzug MJ , Anstead G , et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother, 2006; 50(1):126–133.

van Burik JA , Hare RS , Solomon HF , Corrado ML , Kontoyiannis DP . Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis, 2006; 42(7):e61–e65.